Name: Treatment of Multi-Resistant Infections with Gram-Negative Bacilli, An Issue of Infectious Disease Clinics of North America
Price: 239.46 NZD
Availability: InStock
Author: David L. , NUS Yong Loo Lin School of Public Health (Joint), National University of Singapore/Direc
ISBN: 9780443428814

portada Treatment of Multi-Resistant Infections with Gram-Negative Bacilli, An Issue of Infectious Disease Clinics of North America

Treatment of Multi-Resistant Infections with Gram-Negative Bacilli, An Issue of Infectious Disease Clinics of North America

Type

Physical Book

Publisher

Churchill Livingstone

Author

David L. , NUS Yong Loo Lin School of Public Health (Joint), National University of Singapore/Direc

Collection

The Clinics: Internal Medicine

Year

2026

Pages

240

Format

Hardcover

Dimensions

22.90 x 15.20 cm

ISBN13

9780443428814

Treatment of Multi-Resistant Infections with Gram-Negative Bacilli, An Issue of Infectious Disease Clinics of North America

David L. , Nus Yong Loo Lin School Of Public Health (Joint), National University Of Singapore/Direc (Author) · Churchill Livingstone · Hardcover

New Book Imported to New Zealand

Delivery: 17 Aug - 24 Aug

NZ$ 239.46

Import costs and 15% GST included in the price ✅

NZ$ 239.46

Add to Wishlist

Synopsis "Treatment of Multi-Resistant Infections with Gram-Negative Bacilli, An Issue of Infectious Disease Clinics of North America"

In this issue of Infectious Disease Clinics of North America, guest editor Dr. David L. Paterson brings his considerable expertise to the topic of Current Management of Serious Bacterial Infections Associated with Multi-Drug Resistance. Top experts provide current reviews that highlight innovative solutions to the treatment difficulties faced by clinicians when they encounter multi-resistant bacteria. Articles cover management of VRE infections; AMR in transplant recipients; rapid diagnostic strategies for antibiotic-resistant bacteria causing bloodstream infection; current management strategies for hypervirulent Klebsiella; current management of melioidosis; and more. Contains 16 relevant, practice-oriented topics including current management strategies for Pseudomonas aeruginosa; non-traditional approaches in the treatment of multiresistant gram-negative bacilli; current management strategies for Staphylococcus aureus bloodstream infections; an update on antimicrobial stewardship; and moreProvides in-depth clinical reviews on current management of serious bacterial infections associated with multi-drug resistance, offering actionable insights for clinical practicePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews